Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Ejhaem
|
January 27, 2025
Pneumonia in patients with chronic lymphocytic leukemia treated with venetoclax-based regimens: A real-world analysis of Polish Adult Leukemia Group (PALG)
Elżbieta Kalicińska, Paula Jablonowska-Babij, Marta Morawska, et al.
Journal of Clinical Medicine
|
October 13, 2021
Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study
Elżbieta Kalicińska, Monika Biernat, Justyna Rybka, et al.
Cancers
|
January 8, 2025
Pneumonia in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax-Based Regimens: A Real-World Analysis of the Polish Adult Leukemia Group (PALG)
Elżbieta Kalicińska, Paula Jabłonowska-Babij, Marta Morawska, et al.
Cancers
|
June 26, 2025
RETRACTED: Kalicińska et al. Pneumonia in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax-Based Regimens: A Real-World Analysis of the Polish Adult Leukemia Group (PALG). <i>Cancers</i> 2024, <i>16</i>, 4168
Elżbieta Kalicińska, Paula Jabłonowska-Babij, Marta Morawska, et al.
International Journal of Cardiology
|
March 8, 2017
Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders
Sebastian Szmit, Wojciech Jurczak, Jan Maciej Zaucha, et al.
Cells
|
March 6, 2021
Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma
Joanna Bartosińska, Joanna Purkot, Agnieszka Karczmarczyk, et al.
Journal of Clinical Medicine
|
December 10, 2021
Bendamustine-Based Regimens as Salvage Therapy in Refractory/Relapsed Multiple Myeloma Patients: A Retrospective Real-Life Analysis by the Polish Myeloma Group
Norbert Grzasko, Grzegorz Charlinski, Marta Morawska, et al.
Leukemia & Lymphoma
|
January 18, 2017
Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group
Norbert Grzasko, Roman Hajek, Marek Hus, et al.
Journal of Clinical Medicine
|
February 25, 2023
A Stepwise Screening Protocol for Multiple Myeloma
Marta Morawska, Jadwiga Dwilewicz-Trojaczek, Tomasz Stompór, et al.
Oncology Letters
|
September 27, 2024
Increased abundance of <i>Firmicutes</i> and depletion of <i>Bacteroidota</i> predicts poor outcome in chronic lymphocytic leukemia
Magdalena Paziewska, Monika Szelest, Michał Kiełbus, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Ejhaem
|
January 27, 2025
Pneumonia in patients with chronic lymphocytic leukemia treated with venetoclax-based regimens: A real-world analysis of Polish Adult Leukemia Group (PALG)
Elżbieta Kalicińska, Paula Jablonowska-Babij, Marta Morawska, et al.
Journal of Clinical Medicine
|
October 13, 2021
Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study
Elżbieta Kalicińska, Monika Biernat, Justyna Rybka, et al.
Cancers
|
January 8, 2025
Pneumonia in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax-Based Regimens: A Real-World Analysis of the Polish Adult Leukemia Group (PALG)
Elżbieta Kalicińska, Paula Jabłonowska-Babij, Marta Morawska, et al.
Cancers
|
June 26, 2025
RETRACTED: Kalicińska et al. Pneumonia in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax-Based Regimens: A Real-World Analysis of the Polish Adult Leukemia Group (PALG). <i>Cancers</i> 2024, <i>16</i>, 4168
Elżbieta Kalicińska, Paula Jabłonowska-Babij, Marta Morawska, et al.
International Journal of Cardiology
|
March 8, 2017
Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders
Sebastian Szmit, Wojciech Jurczak, Jan Maciej Zaucha, et al.
Cells
|
March 6, 2021
Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma
Joanna Bartosińska, Joanna Purkot, Agnieszka Karczmarczyk, et al.
Journal of Clinical Medicine
|
December 10, 2021
Bendamustine-Based Regimens as Salvage Therapy in Refractory/Relapsed Multiple Myeloma Patients: A Retrospective Real-Life Analysis by the Polish Myeloma Group
Norbert Grzasko, Grzegorz Charlinski, Marta Morawska, et al.
Leukemia & Lymphoma
|
January 18, 2017
Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group
Norbert Grzasko, Roman Hajek, Marek Hus, et al.
Journal of Clinical Medicine
|
February 25, 2023
A Stepwise Screening Protocol for Multiple Myeloma
Marta Morawska, Jadwiga Dwilewicz-Trojaczek, Tomasz Stompór, et al.
Oncology Letters
|
September 27, 2024
Increased abundance of <i>Firmicutes</i> and depletion of <i>Bacteroidota</i> predicts poor outcome in chronic lymphocytic leukemia
Magdalena Paziewska, Monika Szelest, Michał Kiełbus, et al.
Page
of 6